To clarify the potential intracellular signalling cascade by which biglycan stimulates tumour cell migration, we investigated the effects of biglycan on the activation of NF-κB and ERK 1 and 2, known downstream biglycan signalling pathways25, 26. The gene discussed is BGN; the disease is neoplasm.